Advertisement
Australia markets closed
  • ALL ORDS

    7,899.20
    +33.90 (+0.43%)
     
  • ASX 200

    7,643.60
    +32.40 (+0.43%)
     
  • AUD/USD

    0.6563
    +0.0002 (+0.03%)
     
  • OIL

    76.57
    -2.04 (-2.60%)
     
  • GOLD

    2,045.80
    +15.10 (+0.74%)
     
  • Bitcoin AUD

    77,880.16
    +142.86 (+0.18%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6062
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.0586
    -0.0002 (-0.02%)
     
  • NZX 50

    11,719.82
    +29.57 (+0.25%)
     
  • NASDAQ

    17,937.61
    -67.09 (-0.37%)
     
  • FTSE

    7,706.28
    +21.79 (+0.28%)
     
  • Dow Jones

    39,131.53
    +62.42 (+0.16%)
     
  • DAX

    17,419.33
    +48.88 (+0.28%)
     
  • Hang Seng

    16,725.86
    -17.09 (-0.10%)
     
  • NIKKEI 225

    39,098.68
    +836.48 (+2.19%)
     

ReWalk Robotics Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags

ReWalk Robotics (NASDAQ:RWLK) Full Year 2022 Results

Key Financial Results

  • Net loss: US$19.6m (loss widened by 54% from FY 2021).

  • US$0.31 loss per share (further deteriorated from US$0.27 loss in FY 2021).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

ReWalk Robotics Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) missed analyst estimates by 3.3%.

Looking ahead, revenue is forecast to grow 35% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 6.1% from a week ago.

Risk Analysis

You still need to take note of risks, for example - ReWalk Robotics has 2 warning signs we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here